Antibiotic susceptibility and molecular epidemiology of Acinetobacter calcoaceticus-baumannii complex strains isolated from a referral hospital in northern Vietnam

Journal of Global Antimicrobial Resistance

Volumn 2, Issue 4, 2014, Pages 318-321

  Van, Trang Dinh ^a   Dinh, Quynh Dao ^b   Vu, Phu Dinh ^a   Nguyen, Trung Vu ^a   Pham, Ca Van ^a   Dao, Trinh Tuyet ^a   Phung, Cam Dac ^c   Hoang, Ha Thu Thi ^c   Tang, Nga Thi ^c   Do, Nga Thuy ^b   Nguyen, Kinh Van ^a   Wertheim, Heiman ^b,d  

^a National Hospital of Tropical Diseases   (Viet Nam)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^c NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acinetobacter baumannii; Antibiotic resistance; Genotype; Hospital acquired infection; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM DERIVATIVE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TIGECYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; DEMOGRAPHY; HOSPITAL; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; VIET NAM;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS;

EID: 84916629982     PISSN: 22137165     EISSN: 22137173     Source Type: Journal    
DOI: 10.1016/j.jgar.2014.05.003     Document Type: Article

References (16)

1. L. Dijkshoorn, A. Nemec, and H. Seifert An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii Nat Rev Microbiol 5 2007 939 951
2. F. Perez, A.M. Hujer, K.M. Hujer, B.K. Decker, P.N. Rather, and R.A. Bonomo Global challenge of multidrug-resistant Acinetobacter baumannii Antimicrob Agents Chemother 51 2007 3471 3484
3. C. Wendt, B. Dietze, E. Dietz, and H. Ruden Survival of Acinetobacter baumannii on dry surfaces J Clin Microbiol 35 1997 1394 1397
4. A. Howard, M. O'Donoghue, A. Feeney, and R.D. Sleator Acinetobacter baumannii: an emerging opportunistic pathogen Virulence 3 2012 243 250
5. A.Y. Peleg, H. Seifert, and D.L. Paterson Acinetobacter baumannii: emergence of a successful pathogen Clin Microbiol Rev 21 2008 538 582
6. OXA-51-like carbapenemase gene intrinsic to this species J Clin Microbiol 44 2006 2974 2976
7. H. Seifert, L. Dolzani, R. Bressan, T. van der Reijden, B. van Strijen, and D. Stefanik Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii J Clin Microbiol 43 2005 4328 4335
8. H. Seifert, A. Schulze, R. Baginski, and G. Pulverer Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii J Clin Microbiol 32 1994 1816 1819
9. K.S. Akers, C. Chaney, A. Barsoumian, M. Beckius, W. Zera, and X. Yu Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex J Clin Microbiol 48 2010 1132 1138
10. F.C. Tenover, R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, and D.H. Persing Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing J Clin Microbiol 33 1995 2233 2239
11. J.R. Lo-Ten-Foe, A.M. de Smet, B.M. Diederen, J.A. Kluytmans, and P.H. van Keulen Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains Antimicrob Agents Chemother 51 2007 3726 3730
12. P. Kiratisin, A. Chongthaleong, T.Y. Tan, E. Lagamayo, S. Roberts, and J. Garcia Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study Int J Antimicrob Agents 39 2012 311 316
13. H. Jin, X.M. Xu, Z.H. Mi, Y. Mou, and P. Liu Drug-resistant gene based genotyping for Acinetobacter baumannii in tracing epidemiological events and for clinical treatment within nosocomial settings Chin Med J (Engl) 122 2009 301 306
14. T.-P. Lim, T.-Y. Tan, W. Lee, S. Sasikala, T.-T. Tan, and L.-Y. Hsu In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore PLoS ONE 6 2011 e18485
15. M.E. Pachón-Ibáñez, F. Docobo-Pérez, R. López-Rojas, J. Domínguez-Herrera, M.E. Jiménez-Mejias, and A. García-Curiel Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii Antimicrob Agents Chemother 54 2010 1165 1172
16. H.F. Wertheim Worldwide colistin and polymyxin usage, the 'last' Gram-negative antibiotics: results from an online global survey 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 31 March-3 April 2012 2012 European Society of Clinical Microbiology and Infectious Diseases London, UK [poster]